Table 5.
Characteristic | n | Adjusted PR1 (95% CI) | p |
---|---|---|---|
HIV risk | |||
Men who have sex with men | 706 | Reference | |
Heterosexual | 183 | 1.31 (1.11–1.53) | 0.001 |
Injection drug use | 145 | 1.49 (1.29–1.72) | <0.001 |
Other/Unknown | 94 | 1.15 (0.96–1.38) | 0.12 |
CD4 count (cells/μl)2 | |||
≥500 | 756 | Reference | |
200–499 | 227 | 0.96 (0.84–1.09) | 0.54 |
<200 | 53 | 1.02 (0.80–1.30) | 0.86 |
HIV RNA3 | |||
<75 copies/mL | 936 | Reference | |
≥75 copies/mL | 144 | 1.39 (1.20–1.62) | <0.001 |
Prior clinical AIDS diagnosis | 461 | 0.94 (0.84–1.04) | 0.22 |
Abbreviations: PR = prevalence ratio; CI = confidence interval
Adjusted for all variables in the table, and, sex, 10-year age intervals, race/ethnicity, education and income estimated from Census block group data from patient’s primary residence, insurance type, BMI, Charlson score excluding AIDS, recent depression, unhealthy drinking, tobacco use disorder diagnosis and substance use disorder diagnosis.
802 (9.6%) had unknown CD4 count.
245 (2.9%) had unknown HIV RNA. 75 copies/mL was the lower limit of detection during the study period.